Pinnacle Associates
UTHR icon

Pinnacle Associates’s United Therapeutics UTHR Stock Holding History

Pinnacle Associates’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$462K Buy
852
+3
+0.4% +$1.55K 0.01% 697
2026
Q2 		$460K Sell
849
-5
-0.6% -$2.82K 0.01% 716
2026
Q1 		$506K Sell
854
-151
-15% -$75.2K 0.01% 658
2025
Q4 		$490K Buy
1,005
+195
+24% +$90.8K 0.01% 656
2025
Q3 		$340K Sell
810
-50
-6% -$16.8K ﹤0.01% 719
2025
Q2 		$247K Buy
860
+50
+6% +$14.9K ﹤0.01% 785
2025
Q1 		$250K Hold
810
– – ﹤0.01% 756
2024
Q4 		$286K Buy
+810
New +$298K ﹤0.01% 729
2024
Q3 		– Sell
-910
Closed -$290K – 851
2024
Q2 		$290K Sell
910
-50
-5% -$13.2K ﹤0.01% 695
2024
Q1 		$221K Buy
+960
New +$217K ﹤0.01% 778
2018
Q1 		– Sell
-2,915
Closed -$431K – 713
2017
Q4 		$431K Sell
2,915
-1,060
-27% -$135K 0.01% 518
2017
Q3 		$466K Sell
3,975
-140
-3% -$17.9K 0.01% 503
2017
Q2 		$534K Sell
4,115
-755
-16% -$94.2K 0.01% 495
2017
Q1 		$659K Sell
4,870
-9,309
-66% -$1.41M 0.01% 460
2016
Q4 		$2.03M Sell
14,179
-670
-5% -$85.5K 0.04% 303
2016
Q3 		$1.75M Sell
14,849
-8,868
-37% -$1.07M 0.04% 317
2016
Q2 		$2.51M Sell
23,717
-18,723
-44% -$2.09M 0.05% 272
2016
Q1 		$4.73M Buy
42,440
+30
+0.1% +$3.8K 0.1% 203
2015
Q4 		$6.64M Sell
42,410
-1,435
-3% -$209K 0.14% 158
2015
Q3 		$5.75M Sell
43,845
-1,376
-3% -$221K 0.13% 171
2015
Q2 		$7.87M Sell
45,221
-3,215
-7% -$578K 0.15% 149
2015
Q1 		$8.35M Buy
+48,436
New +$7.38M 0.16% 145

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Livforsakringsbolaget Skandia
Livforsakringsbolaget Skandia Stockholm, Sweden $3.02B AUM 43.19% 1-Year Est. Return
Nepsis Inc
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Pinnacle Associates's UTHR Position: Q3 2026 in Review

Pinnacle Associates increased its United Therapeutics (UTHR) stake by 0.35% in Q3 2026, buying an estimated $1.55K and bringing the position to 852 shares worth $462K. The position accounts for 0.01% of the portfolio, ranked #697.

Pinnacle Associates first reported a position in UTHR in Q1 2015 and has held it in 22 quarters since. The position peaked at $8.35M in Q1 2015. 150 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Pinnacle Associates held 852 shares of United Therapeutics worth $462K as of Q3 2026.
  • Pinnacle Associates bought 3 United Therapeutics shares in Q3 2026, an estimated $1.55K.
  • United Therapeutics made up 0.01% of Pinnacle Associates's portfolio in Q3 2026, its #697 holding.
  • Pinnacle Associates first reported a position in United Therapeutics in Q1 2015 and has held it in 22 quarters since.
  • Pinnacle Associates's United Therapeutics position peaked at $8.35M in Q1 2015.
  • 150 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.